The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...

The company markets and sells these lenses under the "EVO" family for refractive surgery to treat myopia (nearsightedness). ICL sales were $46.9 million for the fourth quarter of 2024 compared to ...

For nearly 30 years, I have confidently helped patients navigate the IOL selection process for both cataract surgery ... ICL sizing and discusses the benefits these lenses offer patients with low ...